Nástroje

iconicon Akciový screener
iconicon Kalendář zisků
iconicon Super investoři

Ostatní

iconicon Návod
IČ: 19940963

5. května 521, 501 01 Turnov
Zásady GDPR
Podmínky služby
Všechna práva vyhrazena @ 2024, Fundamenty.cz
Proudly created by draftspot.net
Outset Medical, Inc.
Outset Medical, Inc.
OM
Valuace
70
Růst
53
Zdraví
75
Cena
$ 12.09
Dnes
+0.04 (0.76%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.2B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
0%
ROA
0%
PE
-1
PS
1
Cena 1R
3-22
⌀ Cena
12.78
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
18-02-2026
Poslední dividenda

Profil

Společnost Outset Medical, Inc. vyvíjí hemodialyzační systém pro dialýzu. Poskytuje systém Hemodialýzy Tablo, který obsahuje kompaktní konzolu s integrovaným čištěním vody, výrobou dialýz na vyžádání a softwarovými a konektivními možnostmi pro dialýzu v akutním a domácím prostředí. Společnost byla dříve známá jako Home Dialysis Plus, Ltd. a v lednu 2015 změnila svůj název na Outset Medical, Inc. Společnost Outset Medical, Inc. byla založena v roce 2003 a sídlí v San Jose v Kalifornii.
Sektor
Healthcare
Odvětví
Medical - Devices
Počet zaměstnanců
354
Založení
2020-09-15
Adresa
3052 Orchard Drive
CEO
Leslie L. Trigg
Web
www.outsetmedical.com

Podobné společnosti

NNOX
Nano-X Imaging Ltd.
$ 2.98
- $ 0.08
INGN
Inogen, Inc.
$ 7.08
+ $ 0.09
QTRX
Quanterix Corporation
$ 5.11
+ $ 0.17
CATX
Perspective Therapeutics, Inc.
$ 2.20
+ $ 0.01
VMD
Viemed Healthcare, Inc.
$ 6.33
- $ 0.04
OMI
Owens & Minor, Inc.
$ 3.05
- $ 0.14
TNYA
Tenaya Therapeutics, Inc.
$ 1.30
+ $ 0.02

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 20252024202320222021202020192018
Total Revenues119.5119.5113.7130.4115.4102.649.915.12.0
Cost of Revenues72.772.775.1101.497.595.063.032.98.1
Gross Profit46.846.838.629.017.87.6-13.0-17.8-6.1
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues28.929.431.429.829.528.727.428.230.530.4
Cost of Revenues16.617.819.618.718.718.817.620.022.823.2
Gross Profit12.211.611.911.110.79.89.88.27.77.2
Operating Income TTM 20252024202320222021202020192018
R&D Expenses0.00.00.057.348.936.728.923.322.9
Selling General & Admin Expenses0.00.00.0141.5130.0101.475.629.217.5
Depreciation & Amortization3.74.35.75.83.30.53.24.41.1
Total Operating Expenses113.2113.5151.9198.8178.9138.1104.452.540.4
Operating Income-66.4-66.7-113.4-169.8-161.0-130.5-117.5-70.3-46.6
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.012.516.1
Selling General & Admin Expenses0.00.00.00.00.00.00.00.032.536.5
Depreciation & Amortization0.90.31.21.31.42.11.51.51.41.8
Total Operating Expenses29.627.428.727.532.633.740.545.145.152.6
Operating Income-17.3-15.8-16.9-16.4-21.9-23.8-30.8-36.9-37.4-45.5
Net Income TTM 20252024202320222021202020192018
Interest Income7.47.49.810.23.30.50.52.51.7
Interest Expense14.014.023.912.73.61.72.44.34.6
Other Expense-14.5-14.2-14.1-2.5-1.6-1.2-4.02.0-0.3
IBT-80.9-80.9-127.5-172.3-162.7-131.7-121.5-68.3-49.8
Income Tax Expense0.70.70.50.50.30.2-0.80.00.0
Net Income-81.7-81.7-128.0-172.8-163.0-131.9-120.7-68.3-49.8
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income1.71.91.92.02.02.12.53.12.32.6
Interest Expense3.43.53.53.65.86.16.06.03.43.2
Other Expense-2.1-1.6-1.6-9.3-3.8-3.9-3.5-2.9-1.1-0.6
IBT-19.4-17.4-18.4-25.7-25.6-27.8-34.3-39.8-38.5-46.1
Income Tax Expense0.10.40.10.10.00.20.20.20.10.1
Net Income-19.5-17.8-18.5-25.8-25.6-27.9-34.5-39.9-38.6-46.2
Per Share Data TTM 20252024202320222021202020192018
EPS$0.00$0.00$0.00$-3.48$-3.38$-2.89$-2.83$-1.61$-1.65
EPS Diluted$0.00$0.00$0.00$-3.48$-3.38$-2.89$-2.83$-1.61$-1.65
Shares Outstanding17.815.23.549.648.245.642.742.330.1
Diluted Shares Outstanding17.815.23.549.648.245.642.742.330.1
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.77$-0.93
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.77$-0.93
Shares Outstanding17.817.817.73.53.43.43.53.450.349.9
Diluted Shares Outstanding17.817.817.73.53.43.43.53.450.349.9
Current Assets TTM 2024202320222021202020192018
Cash And Equivalents37.9124.068.573.2182.3295.036.933.3
Short Term Investments157.034.7134.8214.3157.119.933.2109.5
Total Cash & ST Investments194.8158.7203.3287.5339.5314.970.1142.8
Accounts Receivable34.135.633.028.125.66.53.91.1
Inventory61.659.449.251.539.218.44.63.0
Other Current Assets4.64.55.76.65.56.21.10.8
Total Current Assets295.1258.2291.2373.6409.8345.979.6147.6
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents36.439.675.9124.033.337.932.268.536.336.4
Short Term Investments142.2144.5113.134.7142.3157.0194.7134.8157.7186.4
Total Cash & ST Investments178.6184.1189.0158.7175.6194.8226.9203.3194.0222.8
Accounts Receivable33.034.936.935.634.334.136.533.035.536.9
Inventory49.352.255.859.461.461.655.849.248.344.5
Other Current Assets4.54.34.94.53.94.66.25.76.05.2
Total Current Assets265.4275.6286.6258.2275.3295.1325.4291.2283.8309.4
Long-Term Assets TTM 2024202320222021202020192018
Net Property, Plant & Equipment15.512.118.622.020.223.37.92.9
Goodwill0.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.0
Long-Term Investments3.30.00.00.00.00.00.00.0
Other Long-Term Assets0.55.53.94.533.534.70.80.6
Total Long-Term Assets19.417.622.626.553.757.98.73.5
Total Assets314.5275.8313.8400.1463.5403.888.4151.1
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment8.09.310.512.113.815.517.018.619.520.6
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.00.00.0
Long-Term Investments3.30.00.00.00.03.33.33.33.33.3
Other Long-Term Assets0.53.94.15.53.80.50.50.61.01.1
Total Long-Term Assets11.913.214.717.617.619.420.922.623.825.0
Total Assets277.3288.8301.2275.8292.9314.5346.2313.8307.6334.4
Current Liabilities TTM 2024202320222021202020192018
Accounts Payable5.33.95.80.61.84.95.03.4
Short-Term Debt1.71.83.21.31.20.97.50.5
Other Current Liabilities23.427.034.641.442.427.711.66.1
Current Liabilities43.445.455.351.951.736.724.910.2
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable1.71.41.23.94.35.36.85.82.92.2
Short-Term Debt1.91.91.91.83.53.41.63.23.12.9
Other Current Liabilities18.919.518.027.021.921.729.434.636.232.8
Current Liabilities37.436.934.245.442.443.450.755.353.048.8
Long-Term Liabilities TTM 2024202320222021202020192018
Long-Term Debt197.0200.1134.6101.936.737.721.628.4
Capital Leases3.64.56.16.98.08.90.00.5
Def. Tax Liability3.60.00.00.00.00.00.00.0
Total Liabilities245.9249.0190.9154.189.475.2460.6439.1
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt2.53.496.3200.1200.3200.6200.9134.6101.7101.9
Capital Leases3.23.64.14.54.93.64.16.16.46.8
Def. Tax Liability0.00.00.00.00.03.64.1-130.1-96.8-96.6
Total Liabilities134.9134.0131.3249.0245.1245.9253.0190.9155.5151.3
Total Common Equity TTM 2024202320222021202020192018
Common Stock0.10.10.10.00.00.00.00.0
Retained Earnings-1,036.1-1,089.7-961.7-789.0-626.0-494.1-372.6-287.9
Comprehensive Income-0.30.00.1-0.6-0.20.00.0-0.1
Total Common Equity68.626.8122.9246.0374.1328.6-372.2-288.0
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.00.00.00.10.10.10.10.10.10.1
Retained Earnings-1,151.9-1,134.0-1,115.5-1,089.7-1,064.1-1,036.1-1,001.7-961.7-923.1-877.0
Comprehensive Income0.20.00.10.00.4-0.3-0.30.1-0.3-0.4
Total Common Equity142.4154.8169.926.847.868.693.2122.9152.1183.1
Other TTM 2024202320222021202020192018
Total Debt202.3201.9136.2103.237.838.629.128.9
Book Value68.626.8122.9246.0374.1328.6-372.2-288.0
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value142.4154.8169.926.847.868.693.2122.9152.1183.1
Cash Flow From Operating Activities TTM 20252024202320222021202020192018
Net Income-113.00.0-128.0-172.8-163.0-131.9-121.5-68.3-49.8
Depreciation & Amortization5.80.05.75.85.25.23.21.91.1
Stock-Based Compensation38.00.029.438.627.217.421.40.90.8
Change Working Capital-22.52.2-25.7-0.8-21.1-25.6-5.8-1.6-0.2
Change In Accounts Receivable0.93.80.0-5.1-2.5-19.1-2.6-2.9-0.6
Change In Accounts Payable3.1-3.3-1.95.3-1.3-3.10.70.82.7
Change In Inventories-17.711.80.01.6-14.7-22.0-16.3-5.0-2.2
Other Non-cash Items43.0-48.52.3-2.26.01.61.20.91.8
Cash from Operations-137.70.00.0-131.4-145.7-130.3-99.0-70.3-46.4
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-19.5-17.8-18.5-25.8-25.6-27.9-34.5-39.9-38.60.0
Depreciation & Amortization0.90.30.51.31.4-2.51.51.51.41.5
Stock-Based Compensation4.15.13.53.04.96.49.88.29.110.9
Change Working Capital1.56.07.3-12.62.127.4-11.9-15.54.00.9
Change In Accounts Receivable1.82.90.6-1.5-1.93.00.5-3.52.51.4
Change In Accounts Payable-1.10.30.3-2.8-0.40.5-1.50.93.10.6
Change In Inventories1.53.03.63.72.113.2-6.2-7.0-1.0-3.5
Other Non-cash Items3.50.12.48.40.7-23.921.720.50.80.0
Cash from Operations0.00.00.00.00.00.00.00.0-24.4-34.0
Cash Flow From Investing Activities TTM 20252024202320222021202020192018
Capital Expenditure-2.3-0.8-0.9-3.4-8.3-3.1-9.1-3.3-1.8
Acquisitions-55.10.00.00.00.00.00.00.00.0
Investments-202.9-222.0-156.6-172.3-261.2-178.4-32.9-91.9-132.3
Sales of Investment238.3125.1261.4258.8203.239.045.9169.565.3
Other Investing Activities34.60.00.00.00.00.00.00.00.0
Cash from Investing33.10.00.083.0-66.3-142.53.974.3-68.8
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-0.2-0.2-0.3-0.10.0-0.4-0.1-0.4-1.1-0.8
Acquisitions0.00.00.00.00.00.00.00.0-24.5-30.6
Investments-28.2-40.1-57.3-96.3-6.1128.4-29.8-98.7-51.0-23.4
Sales of Investment37.043.226.518.4114.338.368.940.075.554.0
Other Investing Activities0.00.00.00.00.00.00.00.024.530.6
Cash from Investing0.00.00.00.00.00.00.00.023.429.8
Cash Flow From Financing Activities TTM 20252024202320222021202020192018
Debt Repaid-99.70.00.033.2-31.20.0-31.00.00.0
Debt Issued198.6201.965.766.296.6-0.840.50.228.9
Issuance of Common Stock72.80.00.010.40.0149.1254.80.0134.6
Repurchase of Common Stock-2.10.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.0
Other Financing Activities137.20.00.010.4104.111.1161.90.30.3
Cash from Financing106.00.00.043.772.9160.1385.70.2134.9
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued3.2-0.5-94.6-103.7-0.2-0.2-0.266.333.0-0.2
Issuance of Common Stock0.00.00.00.00.00.00.00.00.04.1
Repurchase of Common Stock0.00.00.00.00.02.1-2.10.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.033.24.1
Cash from Financing0.00.00.00.00.00.00.00.033.24.1
Cash position TTM 20252024202320222021202020192018
Net Change in Cash1.5-88.555.5-4.7-139.1-112.6290.64.319.7
Closing Cash Balance37.938.8127.371.876.5215.7328.337.733.4
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-0.9-3.1-36.4-48.190.7-1.25.7-36.332.2-0.1
Closing Cash Balance38.839.842.979.3127.336.637.932.271.839.6
Free Cash Flow TTM 20252024202320222021202020192018
Free Cash Flow-140.0-47.1-117.2-134.8-154.1-133.4-108.1-73.6-48.2
Real Free Cash Flow-178.0-47.1-146.6-173.4-181.3-150.8-129.6-74.5-49.0
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-9.7-6.5-5.1-25.8-16.5-21.0-33.5-46.3-25.5-34.8
Real Free Cash Flow-13.8-11.6-8.6-28.8-21.5-27.4-43.3-54.5-34.6-45.7
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-0.8-91.7179.3
P/S0.6156.8390.6
P/B0.543.1113.4
P/FCF-1.1-82.7149.9
Market cap$0.2$0.3
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %20.2 %0 %
Debt to Income-3.9 %-46.1 %0 %
Debt to Free cash flow-5 %-496.8 %0 %
Interest expense percentage-21 %-8.2 %11.2 %
Current ratio7.1 6.4 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-57.4 %-87.8 %0 %
ROA-29.5 %-35.3 %0 %
CapEx to Revenue0.7 %7 %6 %
RaD to Revenue0 %52.6 %0 %
ROEM337,502.8 171107.1

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin39.1 %-3.3 %61.9 %
Operating margin-55.6 %-178.4 %17.9 %
Net margin-68.3 %-178.1 %13 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding17.8 mil 41.1 mil
Employee count0.4 tis 0.4 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás
Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader